85 related articles for article (PubMed ID: 6850607)
1. Urinary excretion of modified nucleosides in patients with malignant mesothelioma.
Fischbein A; Sharma OK; Selikoff IJ; Borek E
Cancer Res; 1983 Jun; 43(6):2971-4. PubMed ID: 6850607
[TBL] [Abstract][Full Text] [Related]
2. Tumor markers derived from nucleic acid components.
Borek E; Waalkes TP; Gehrke CW
Cancer Detect Prev; 1983; 6(1-2):67-71. PubMed ID: 6883395
[TBL] [Abstract][Full Text] [Related]
3. Transfer RNA breakdown products in the urine of asbestos workers.
Fischbein A; Sharma OK; Solomon S; Buschman F; Apell G; Kohn M; Selikoff IJ; Bekesi JG; Borek E
Cancer Detect Prev; 1984; 7(4):247-52. PubMed ID: 6488216
[TBL] [Abstract][Full Text] [Related]
4. Patterns of urinary excretion of modified nucleosides.
Gehrke CW; Kuo KC; Waalkes TP; Borek E
Cancer Res; 1979 Apr; 39(4):1150-3. PubMed ID: 421198
[TBL] [Abstract][Full Text] [Related]
5. Urinary excretion of modified nucleosides in patients with acquired immune deficiency syndrome (AIDS) and individuals at high risk of AIDS.
Fischbein A; Sharma OK; Valciukas JA; Bekesi JG; Buschman F; Apell G; Kohn M; Boesch RR; Teirstein A; Selikoff IJ
Cancer Detect Prev; 1985; 8(1-2):271-7. PubMed ID: 4064047
[TBL] [Abstract][Full Text] [Related]
6. Excretion pattern investigation of urinary normal and modified nucleosides of breast cancer patients by RP-HPLC and factor analysis method.
Xu G; Schmid HR; Lu X; Liebich HM; Lu P
Biomed Chromatogr; 2000 Nov; 14(7):459-63. PubMed ID: 11113924
[TBL] [Abstract][Full Text] [Related]
7. Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
Hsu WY; Chen WT; Lin WD; Tsai FJ; Tsai Y; Lin CT; Lo WY; Jeng LB; Lai CC
Clin Chim Acta; 2009 Apr; 402(1-2):31-7. PubMed ID: 19135043
[TBL] [Abstract][Full Text] [Related]
8. Analysis of urinary nucleosides as helper tumor markers in hepatocellular carcinoma diagnosis.
Jeng LB; Lo WY; Hsu WY; Lin WD; Lin CT; Lai CC; Tsai FJ
Rapid Commun Mass Spectrom; 2009 Jun; 23(11):1543-9. PubMed ID: 19399767
[TBL] [Abstract][Full Text] [Related]
9. Study of urinary nucleosides as biological marker in cancer patients analyzed by micellar electrokinetic capillary chromatography.
Zheng YF; Xu GW; Liu DY; Xiong JH; Zhang PD; Zhang C; Yang Q; Lv S
Electrophoresis; 2002 Dec; 23(24):4104-9. PubMed ID: 12481266
[TBL] [Abstract][Full Text] [Related]
10. Increased urinary levels of RNA catabolites in mice as early indicators for malignant growth.
Thomale J; Luz A; Nass G
Cancer Detect Prev; 1983; 6(1-2):73-6. PubMed ID: 6192923
[TBL] [Abstract][Full Text] [Related]
11. Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring.
Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Liu BY; Zhu ZG
J Gastroenterol Hepatol; 2005 Dec; 20(12):1913-9. PubMed ID: 16336453
[TBL] [Abstract][Full Text] [Related]
12. Multilayer perceptron tumour diagnosis based on chromatography analysis of urinary nucleosides.
Seidel P; Seidel A; Herbarth O
Neural Netw; 2007 Jul; 20(5):646-51. PubMed ID: 17275256
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance and prognostic value of urinary nucleosides in breast cancer patients.
Zheng YF; Kong HW; Xiong JH; Lv S; Xu GW
Clin Biochem; 2005 Jan; 38(1):24-30. PubMed ID: 15607313
[TBL] [Abstract][Full Text] [Related]
14. [Application of urinary nucleosides in the diagnosis and surgical monitoring of colorectal cancer].
Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Yu BM
Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):564-8. PubMed ID: 15938925
[TBL] [Abstract][Full Text] [Related]
15. Age-dependence of urinary normal and modified nucleosides in childhood as determined by reversed-phase high-performance liquid chromatography.
Liebich HM; Müller-Hagedorn S; Bacher M; Scheel-Walter HG; Lu X; Frickenschmidt A; Kammerer B; Kim KR; Gérard H
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(2):275-83. PubMed ID: 15639449
[TBL] [Abstract][Full Text] [Related]
16. Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers.
Langridge JI; McClure TD; el-Shakawi S; Fielding A; Schram KH; Newton RP
Rapid Commun Mass Spectrom; 1993 Jun; 7(6):427-34. PubMed ID: 8329765
[TBL] [Abstract][Full Text] [Related]
17. Analysis, identification and determination of urinary modified nucleosides of cancer and AIDS patients.
Nakano K; Yasaka T; Nakao T; Schram KH; Hammargren WM
Nucleic Acids Symp Ser; 1990; (22):31-2. PubMed ID: 2101906
[TBL] [Abstract][Full Text] [Related]
18. Modified nucleosides in asbestos workers at high risk of malignant disease: results of a preliminary study applying discriminant analysis.
Solomon SJ; Fischbein A; Sharma OK; Borek E
Br J Ind Med; 1985 Aug; 42(8):560-2. PubMed ID: 4016008
[TBL] [Abstract][Full Text] [Related]
19. Analysis of modified nucleosides in the urine of patients with malignant cancer by liquid chromatography/electrospray ionization mass spectrometry.
Li HY; Wang SM; Liu HM; Li J; Han D; Bu SS; Zhang MZ
Rapid Commun Mass Spectrom; 2008 Oct; 22(20):3161-71. PubMed ID: 18798199
[TBL] [Abstract][Full Text] [Related]
20. High turnover rate of transfer RNA in tumor tissue.
Borek E; Baliga BS; Gehrke CW; Kuo CW; Belman S; Troll W; Waalkes TP
Cancer Res; 1977 Sep; 37(9):3362-6. PubMed ID: 884680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
